Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Armata Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 23 | 25 | +2 |
| Shares | 1.28M | 1.29M | +7.01K (+0.5%) |
| Value | $3.85M | $4.17M | +$328.5K (+8.5%) |
New holders (3)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Larson Financial Group LLC | 967 | $3.13K | 0.00% |
| Tennessee Valley Asset Management Partners | 279 | $904 | 0.00% |
| JPMorgan Chase & Co | 105 | $340 | 0.00% |
Sold out (1)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Dimensional Fund Advisors LP | 11,472 | $34.4K |